359 related articles for article (PubMed ID: 26896487)
1. ThPOK represses CXXC5, which induces methylation of histone H3 lysine 9 in Cd40lg promoter by association with SUV39H1: implications in repression of CD40L expression in CD8+ cytotoxic T cells.
Tsuchiya Y; Naito T; Tenno M; Maruyama M; Koseki H; Taniuchi I; Naoe Y
J Leukoc Biol; 2016 Aug; 100(2):327-38. PubMed ID: 26896487
[TBL] [Abstract][Full Text] [Related]
2. Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway.
Wakabayashi Y; Tamiya T; Takada I; Fukaya T; Sugiyama Y; Inoue N; Kimura A; Morita R; Kashiwagi I; Takimoto T; Nomura M; Yoshimura A
J Biol Chem; 2011 Oct; 286(41):35456-35465. PubMed ID: 21862595
[TBL] [Abstract][Full Text] [Related]
3. The epigenetic control of stemness in CD8
Pace L; Goudot C; Zueva E; Gueguen P; Burgdorf N; Waterfall JJ; Quivy JP; Almouzni G; Amigorena S
Science; 2018 Jan; 359(6372):177-186. PubMed ID: 29326266
[TBL] [Abstract][Full Text] [Related]
4. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1.
Zhao M; Wu X; Zhang Q; Luo S; Liang G; Su Y; Tan Y; Lu Q
Arthritis Res Ther; 2010; 12(6):R227. PubMed ID: 21192791
[TBL] [Abstract][Full Text] [Related]
5. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
6. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase.
Wang H; Cao R; Xia L; Erdjument-Bromage H; Borchers C; Tempst P; Zhang Y
Mol Cell; 2001 Dec; 8(6):1207-17. PubMed ID: 11779497
[TBL] [Abstract][Full Text] [Related]
7. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression.
Fujita N; Watanabe S; Ichimura T; Tsuruzoe S; Shinkai Y; Tachibana M; Chiba T; Nakao M
J Biol Chem; 2003 Jun; 278(26):24132-8. PubMed ID: 12711603
[TBL] [Abstract][Full Text] [Related]
8. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
9. SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR.
Kamoi K; Yamamoto K; Misawa A; Miyake A; Ishida T; Tanaka Y; Mochizuki M; Watanabe T
Retrovirology; 2006 Jan; 3():5. PubMed ID: 16409643
[TBL] [Abstract][Full Text] [Related]
10. Yin Yang-1 suppresses CD40 ligand-CD40 signaling-mediated anti-inflammatory cytokine interleukin-10 expression in pulmonary adventitial fibroblasts by promoting histone H3 tri-methylation at lysine 27 modification on interleukin-10 promoter.
Pan YY; Yang JX; Xu YF; Mao W
Cell Biol Int; 2020 Jul; 44(7):1544-1555. PubMed ID: 32198816
[TBL] [Abstract][Full Text] [Related]
11. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis.
Tachibana M; Sugimoto K; Nozaki M; Ueda J; Ohta T; Ohki M; Fukuda M; Takeda N; Niida H; Kato H; Shinkai Y
Genes Dev; 2002 Jul; 16(14):1779-91. PubMed ID: 12130538
[TBL] [Abstract][Full Text] [Related]
12. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
Cai L; Ma X; Huang Y; Zou Y; Chen X
Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
[TBL] [Abstract][Full Text] [Related]
13. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase.
Fuks F; Hurd PJ; Deplus R; Kouzarides T
Nucleic Acids Res; 2003 May; 31(9):2305-12. PubMed ID: 12711675
[TBL] [Abstract][Full Text] [Related]
14. Silencing of the Il2 gene transcription is regulated by epigenetic changes in anergic T cells.
Bandyopadhyay S; Montagna C; Macian F
Eur J Immunol; 2012 Sep; 42(9):2471-83. PubMed ID: 22684523
[TBL] [Abstract][Full Text] [Related]
15. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
16. Rb targets histone H3 methylation and HP1 to promoters.
Nielsen SJ; Schneider R; Bauer UM; Bannister AJ; Morrison A; O'Carroll D; Firestein R; Cleary M; Jenuwein T; Herrera RE; Kouzarides T
Nature; 2001 Aug; 412(6846):561-5. PubMed ID: 11484059
[TBL] [Abstract][Full Text] [Related]
17. Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.
Sewalt RG; Lachner M; Vargas M; Hamer KM; den Blaauwen JL; Hendrix T; Melcher M; Schweizer D; Jenuwein T; Otte AP
Mol Cell Biol; 2002 Aug; 22(15):5539-53. PubMed ID: 12101246
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
[TBL] [Abstract][Full Text] [Related]
19. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression.
Wang H; An W; Cao R; Xia L; Erdjument-Bromage H; Chatton B; Tempst P; Roeder RG; Zhang Y
Mol Cell; 2003 Aug; 12(2):475-87. PubMed ID: 14536086
[TBL] [Abstract][Full Text] [Related]
20. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
